GWN Securities’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.49M Sell
4,579
-526
-10% -$537K 0.92% 14
2026
Q1
$4.7M Sell
5,105
-116
-2% -$118K 0.9% 17
2025
Q4
$5.61M Buy
5,221
+368
+8% +$352K 1.14% 13
2025
Q3
$3.75M Sell
4,853
-200
-4% -$149K 0.87% 20
2025
Q2
$3.99M Sell
5,053
-3,928
-44% -$3.05M 0.74% 37
2025
Q1
$7.35M Buy
8,981
+4,235
+89% +$3.52M 0.41% 52
2024
Q4
$3.73M Buy
+4,746
New +$3.93M 1% 16

Other funds holding LLY

GWN Securities's LLY Position: Q2 2026 in Review

GWN Securities reduced its Eli Lilly (LLY) stake by 10% in Q2 2026, selling an estimated $537K and leaving 4,579 shares worth $5.49M. The position accounts for 0.92% of the portfolio, ranked #14.

GWN Securities first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.35M in Q1 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • GWN Securities held 4,579 shares of Eli Lilly worth $5.49M as of Q2 2026.
  • GWN Securities sold 526 Eli Lilly shares in Q2 2026, an estimated $537K.
  • Eli Lilly made up 0.92% of GWN Securities's portfolio in Q2 2026, its #14 holding.
  • GWN Securities first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • GWN Securities's Eli Lilly position peaked at $7.35M in Q1 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on GWN Securities's 13F filing for Q2 2026, filed 5 Aug 2026.